Meyers L, Gutiérrez A, Boyle C, Terry F, McGonnigal B, Salazar A, et al. Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. NPJ Vaccines. 2021;6:71 pubmed publisher

Nemattalab M, Shenagari M, Taheri M, Mahjoob M, Nazari Chamaki F, Mojtahedi A, et al. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine. 2020;126:154866 pubmed publisher

Rodrigues da Silva R, Correa Moreira D, Soares I, De Luca P, Totino P, Morgado F, et al. Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9. Vaccine. 2019;37:306-313 pubmed publisher

Magnusson S, Altenburg A, Bengtsson K, Bosman F, de Vries R, Rimmelzwaan G, et al. Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunol Res. 2018;66:224-233 pubmed publisher

Krotova O, Starodubova E, Petkov S, Kostic L, Agapkina J, Hallengärd D, et al. Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells. PLoS ONE. 2013;8:e62720 pubmed publisher